CVS Bay Area Inc.

As of August 31, 2024, CVS Bay Area Inc. carries a market capitalization of 2.86B, placing it among publicly traded companies globally. Its enterprise value stands at 5.65B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

CVS Bay Area Inc.'s next confirmed earnings release is scheduled for January 13, 2027.

As of August 31, 2024, CVS Bay Area Inc. has 4.94M shares outstanding.

As of August 31, 2024, CVS Bay Area Inc. trades at a trailing price-to-earnings ratio of 2.24. The price-to-sales ratio is 0.37, and the price-to-book ratio stands at 0.69.

As of August 31, 2024, CVS Bay Area Inc. trades at an EV/EBITDA multiple of 11.59 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.74 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 11.59 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 5.65B versus a market cap of 2.86B, with the gap driven by net debt and cash on the balance sheet.

As of August 31, 2024, CVS Bay Area Inc. maintains a current ratio of 1.08, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 127.13, indicating elevated leverage, while an interest coverage ratio of 13.50 demonstrates strong ability to service its debt obligations.

Over the twelve months ended August 31, 2024, CVS Bay Area Inc. posted a return on equity (ROE) of 36.06, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 12.50, measuring how efficiently the asset base is converted into earnings. The company generates approximately 37.83M in revenue per employee across its workforce of 202.75, a quick read on workforce productivity versus industry peers. Inventory turnover of 82.22 indicates how many times CVS Bay Area Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended August 31, 2024, CVS Bay Area Inc. recorded an income tax benefit of -12.81M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. Taxes are levied on pretax income of 1.26B, leaving 1.27B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, CVS Bay Area Inc.'s stock has declined approximately 15.18% over the past 52 weeks. The 50-day moving average sits at 493.62, while the 200-day moving average is 496.40.

Over the twelve months ended August 31, 2024, CVS Bay Area Inc. generated 7.67B in revenue and converted that into 1.27B in net income, yielding earnings per share of 258.06. EBITDA reached 487.55M, while operating income came in at 487.56M.

As of August 31, 2024, CVS Bay Area Inc. holds 2.45B in cash and equivalents against 5.24B in total debt, resulting in a net debt position of 2.79B. Total book value stands at 4.12B, with working capital of 240.10M providing operational flexibility.

Over the twelve months ended August 31, 2024, CVS Bay Area Inc. posted a gross margin of 46.01, reflecting its pricing power and cost economics. The operating margin of 6.36 and net profit margin of 16.61 provide insight into operational efficiency.

CVS Bay Area Inc.'s most recent stock split took place on August 29, 2016 with a 10:1 split ratio.

As of August 31, 2024, CVS Bay Area Inc. has an Altman Z-Score of 1.48, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.